Clinical outcome | Group A (nonoperative) | Group B (operative) | p-value |
---|
baseline | follow-up | MD | baseline | follow-up | MD |
---|
AOFAS-AHS pain | 28 (26–29) | 30* (28–32) | 2 (− 1–5) | 28 (26–30) | 37** (34–39) | 9 (6–12) | .002 |
AOFAS-AHS function | 42 (41–43) | 43* (41–45) | 1 (− 1–3) | 42 (40–43) | 47** (45–49) | 6 (4–8) | .04 |
AOFAS-AHS alignment | 1 (0–2) | 5** (4–6) | 4 (3–6) | 1 (0–2) | 10** (9–11) | 9 (7–10) | .001 |
AOFAS-AHS total | 70 (68–73) | 78** (74–82) | 8 (3–12) | 71 (68–73) | 94** (89–98) | 24 (19–29) | < .0005 |
- The estimated means were adjusted by inverse probability of treatment weights (IPTW) and follow-up duration (covariates were calculated at 6.5 years of follow-up), using the patient as random effect to avoid violation of the principle of independence in bilateral cases. 95% confidence interval of the estimated mean is reported in brackets
- MD = Mean Difference between baseline and latest follow-up AOFAS-AHS
- The asterisks refer to the statistical difference between baseline and follow-up values within the same group. *: difference is significant at p < .05. **: difference is significant at p < .0005
- The P-value in the last column is referred to the statistical difference between the MD of the two groups